Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-03
DOI
10.3389/fmed.2021.792135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutation rates and selection on synonymous mutations in SARS-CoV-2
- (2021) Nicola De Maio et al. Genome Biology and Evolution
- Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
- (2021) Rui Wang et al. GENOMICS
- Identification of a SARS-CoV-2 Variant with L452R and E484Q Neutralization Resistance Mutations
- (2021) Michelle Verghese et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike mutation T478K
- (2021) Simone Di Giacomo et al. JOURNAL OF MEDICAL VIROLOGY
- Comprehensive large-scale nucleic acid–testing strategies support China’s sustained containment of COVID-19
- (2021) Zhongjie Li et al. NATURE MEDICINE
- Novel coronavirus disease 2019 (COVID-19) pandemic: From transmission to control with an interdisciplinary vision
- (2021) Uttpal Anand et al. ENVIRONMENTAL RESEARCH
- Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021
- (2021) Jeromie Wesley Vivian Thangaraj et al. JOURNAL OF INFECTION
- SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
- (2021) Isabella A T M Ferreira et al. JOURNAL OF INFECTIOUS DISEASES
- Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
- (2021) Michela Antonelli et al. LANCET INFECTIOUS DISEASES
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- The mutation that helps Delta spread like wildfire
- (2021) Ewen Callaway NATURE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
- (2021) Jocelyn Keehner et al. NEW ENGLAND JOURNAL OF MEDICINE
- The total number and mass of SARS-CoV-2 virions
- (2021) Ron Sender et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Covid-19: How many variants are there, and what do we know about them?: Video 1
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Lifting of COVID-19 restrictions in the UK and the Delta variant
- (2021) Talha Khan Burki Lancet Respiratory Medicine
- SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
- (2021) Daniel Martínez-Flores et al. Frontiers in Immunology
- Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
- (2021) Uttpal Anand et al. Frontiers in Immunology
- SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
- (2021) Frank Konings et al. Nature Microbiology
- Comparative Study of Acute Lung Injury in COVID-19 and Non-COVID-19 Patients
- (2021) Jianguo Zhang et al. Frontiers in Medicine
- Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases
- (2021) Jianguo Zhang et al. Experimental Hematology & Oncology
- The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
- (2021) Elisa Teyssou et al. JOURNAL OF INFECTION
- Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
- (2021) Varda Shoshan-Barmatz et al. Frontiers in Physiology
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
- (2020) Heshui Shi et al. LANCET INFECTIOUS DISEASES
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Traditional Chinese Medicine for COVID-19 Treatment
- (2020) Jun-ling Ren et al. PHARMACOLOGICAL RESEARCH
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
- (2020) B. Coutard et al. ANTIVIRAL RESEARCH
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Differentiation of COVID‐19 from seasonal influenza: A multicenter comparative study
- (2020) Jianguo Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- The coding capacity of SARS-CoV-2
- (2020) Yaara Finkel et al. NATURE
- Temporal signal and the phylodynamic threshold of SARS-CoV-2
- (2020) Sebastian Duchene et al. Virus Evolution
- Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
- (2020) Erik Volz et al. CELL
- Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
- (2020) Eric J. Lenze et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started